Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
The drug is now approved in the European Union (EU) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD), characterized by raised blood eosinophils. The approval of the COPD indication represents the sixth approved indication for Dupixent in the EU. The approval was mostly expected as the European Medicines Agency's Committee for Medicinal Products for Human Use gave a positive opinion recommending the approval of Dupixent for COPD in May 2024. This latest EC approval is based on positive results from two late-stage studies, BOREAS and NOTUS, which evaluated the efficacy and safety of Dupixent in adults who were current or former smokers with moderate-to-severe COPD with evidence of type 2 inflammation. Results showed that Dupixent significantly reduced exacerbations and improved lung function and health-related quality of life. COPD is a respiratory disease that damages the lungs and causes progressive lung function decli
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Dupixent “addresses current gap” in COPD biologics landscape [Yahoo! Finance]Yahoo! Finance
- Three Solid Euronext Paris Dividend Stocks With Yields Up To 7.9% [Yahoo! Finance]Yahoo! Finance
- French State Investment Firm Eyes Stake in Sanofi Consumer Unit [Yahoo! Finance Canada]Yahoo! Finance Canada
- French State Investment Firm Eyes Stake in Sanofi Consumer Unit [BNN Bloomberg (Canada)]BNN Bloomberg
- Kidney Transplant Market to Grow at a 3.3% CAGR from 2024 to 2034, Fueled by Healthcare Spending and Renal Calculi Retrieval Devices Landscape | TMR [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 7/2/24 - Form 6-K
- 6/28/24 - Form 11-K
- 6/28/24 - Form 11-K
- SNY's page on the SEC website